Jump Financial, LLC Spring Works Therapeutics, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$36.5 - $52.5 $148,737 - $213,937	4,075 New	4,075 $200,000
Q1 2023 Oct 21, 2024	BUY	$24.97 - $34.05 $322,113 - $439,244	12,900 New	12,900 $332,000
Q1 2023 May 03, 2023	SELL	$24.97 - $34.05 $859,492 - $1.17 Million	-34,421 Reduced 72.74%	12,900 $332,000
Q4 2022 Feb 13, 2023	BUY	$21.73 - $28.72 $732,648 - $968,323	33,716 Added 247.82%	47,321 $1.23 Million
Q3 2022 Nov 07, 2022	SELL	$24.1 - $39.66 $662,629 - $1.09 Million	-27,495 Reduced 66.9%	13,605 $388,000
Q2 2022 Aug 09, 2022	BUY	$18.36 - $60.07 $754,596 - $2.47 Million	41,100 New	41,100 $1.01 Million

239

70.8M

151K

255K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $3.58B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.